CG Oncology, Inc. Common stock (CGON) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$59.73
Day's range
$62.63

Cg Oncology Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VANGUARD GROUP INC 01/29/2026 6.54 M $271.52 M   -0.57% 8.52%
DECHENG CAPITAL LLC 02/12/2026 6.37 M $264.55 M   0.00% 8.30%
WELLINGTON MANAGEMENT GROUP LLP 02/17/2026 6.00 M $249.11 M   8.83% 7.82%
BLACKROCK, INC. 02/12/2026 4.84 M $201.09 M   5.60% 6.31%
FMR LLC 02/17/2026 4.30 M $178.46 M   11.18% 5.60%
TCG CROSSOVER MANAGEMENT, LLC 02/17/2026 3.67 M $152.39 M   0.00% 4.78%
PRICE T ROWE ASSOCIATES INC /MD/ 02/17/2026 3.44 M $142.96 M   116.72% 4.49%
STATE STREET CORP 02/13/2026 3.00 M $124.42 M   46.42% 3.91%
FORESITE CAPITAL MANAGEMENT VI LLC 02/17/2026 2.22 M $92.24 M   0.00% 2.90%
RTW INVESTMENTS, LP 02/17/2026 2.01 M $83.54 M   18.28% 2.62%
UBS GROUP AG 01/29/2026 1.92 M $79.87 M   -9.52% 2.51%
BRAIDWELL LP 02/17/2026 1.87 M $77.67 M   -43.03% 2.44%
ALLIANCEBERNSTEIN L.P. 02/17/2026 1.61 M $66.99 M   -24.54% 2.10%
FRANKLIN RESOURCES INC 02/11/2026 1.56 M $64.84 M   6.28% 2.04%
ORBIMED ADVISORS LLC 02/17/2026 1.52 M $62.97 M   -12.18% 1.98%
04/02/2026 1.52 M $62.91 M   100.00% 1.97%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 1.51 M $62.77 M   2.60% 1.97%
AVIDITY PARTNERS MANAGEMENT LP 02/13/2026 1.47 M $61.15 M   -8.01% 1.92%
DV TRADING LLC 02/17/2026 1.44 M $59.76 M   100.00% 1.88%
PICTET ASSET MANAGEMENT HOLDING SA 01/29/2026 1.35 M $56.03 M   2.35% 1.76%
GOLDMAN SACHS GROUP INC 03/25/2026 1.32 M $55.00 M   -3.09% 1.73%
BANK OF AMERICA CORP /DE/ 02/17/2026 1.19 M $49.41 M   59.02% 1.55%
ACORN CAPITAL ADVISORS, LLC 02/17/2026 1.13 M $46.98 M   0.00% 1.47%
POLAR CAPITAL HOLDINGS PLC 02/17/2026 1.10 M $45.62 M   0.00% 1.43%
UBS ASSET MANAGEMENT AMERICAS INC 02/13/2026 1.09 M $45.29 M   39.80% 1.42%
FORESITE CAPITAL MANAGEMENT V, LLC 02/17/2026 1.00 M $41.69 M   0.00% 1.31%
KYNAM CAPITAL MANAGEMENT, LP 02/17/2026 945.83 K $39.27 M   -52.83% 1.23%
CANDRIAM S.C.A. 04/30/2026 797.62 K $33.12 M   -23.15% 1.04%
ECOR1 CAPITAL, LLC 02/17/2026 772.00 K $32.05 M   100.00% 1.01%
CLEARBRIDGE INVESTMENTS, LLC 02/11/2026 705.01 K $29.27 M   14.85% 0.92%
CITADEL ADVISORS LLC 02/17/2026 681.19 K $28.28 M   185.29% 0.89%
CAPTION MANAGEMENT, LLC 02/17/2026 602.40 K $25.01 M   100.00% 0.79%
OCTAGON CAPITAL ADVISORS LP 02/17/2026 600.00 K $24.91 M   100.00% 0.78%
JPMORGAN CHASE & CO 02/11/2026 586.83 K $24.37 M   157.52% 0.76%
MORGAN STANLEY 02/13/2026 545.02 K $22.63 M   -15.16% 0.71%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 542.70 K $22.53 M   3.27% 0.71%
ENSIGN PEAK ADVISORS, INC 02/12/2026 530.76 K $22.04 M   33.87% 0.69%
WOODLINE PARTNERS LP 02/17/2026 492.50 K $20.45 M   -13.82% 0.64%
02/17/2026 492.50 K $20.45 M   100.00% 0.64%
NORTHERN TRUST CORP 02/17/2026 481.94 K $20.01 M   -1.91% 0.63%
DIMENSIONAL FUND ADVISORS LP 02/12/2026 461.13 K $19.15 M   1.94% 0.60%
TIMESSQUARE CAPITAL MANAGEMENT, LLC 02/06/2026 426.02 K $17.69 M   -15.39% 0.56%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 02/19/2026 422.59 K $17.55 M   100.00% 0.55%
OPALEYE MANAGEMENT INC. 04/13/2026 410.00 K $17.02 M   0.00% 0.53%
CAPTION MANAGEMENT, LLC 02/17/2026 400.00 K $16.61 M   422.88% 0.52%
SILVERARC CAPITAL MANAGEMENT, LLC 02/12/2026 361.16 K $15.00 M   -43.42% 0.47%
EVENTIDE ASSET MANAGEMENT, LLC 02/13/2026 312.45 K $12.97 M   100.00% 0.41%
EVERSEPT PARTNERS, LP 02/17/2026 308.47 K $12.81 M   100.00% 0.40%
CAPTION MANAGEMENT, LLC 02/17/2026 306.85 K $12.74 M   100.00% 0.40%
ROSALIND ADVISORS, INC. 02/12/2026 300.00 K $12.46 M   0.00% 0.39%

Cg Oncology Inc. institutional Ownership - FAQ's

During the previous two years, 252 institutional investors and hedge funds held shares of Cg Oncology Inc.. The most heavily invested institutionals were:

UBS Group AG: 1.31 M

Candriam S.C.A.: 542,036

JENNISON ASSOCIATES LLC: 476,136

VANGUARD FIDUCIARY TRUST CO: 470,257

Fisher Asset Management, LLC: 465,033

DIMENSIONAL FUND ADVISORS LP: 438,673

107.70% of Cg Oncology Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 83.02 M shares in the last 24 months. This purchase volume represents approximately $5.09 B in transactions.